Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Sarcoma, Ewing 2Vaginal Neoplasms 1Prostatic Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Ganglioneuroblastoma 1

Interventions

Cisplatin 6pembrolizumab 3Nivolumab 3Magnetic Resonance Spectroscopy 3Fulvestrant 3palbociclib 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiation Dose Hypofractionation 2Radiation 2Platinum 2Paclitaxel 2Fluorouracil 2Fluorodeoxyglucose F18 2Drug Therapy 2Congresses as Topic 2Carboplatin 2Brachytherapy 2Biopsy 2Bevacizumab 2Axitinib 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 21,2-diaminocyclohexaneplatinum II citrate 2zimberelimab 1ulixertinib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tisotumab vedotin 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Congresses as Topic × 30 days × Clear all
NCT02466971 2026-05-29

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT02595879 2026-05-29

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
21 enrolled 22 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡